뉴스벤징가
FDA Greenlights GSK’s First Lung Cancer Drug Ahead of Schedule
· 발표
기사 요약
GSK wins early FDA approval for Jideytro, a targeted treatment for adults with advanced ROS1-positive non-small cell lung cancer.
기사 원문에서 발췌했어요.뉴스 본문을 불러오고 있어요.
GSK wins early FDA approval for Jideytro, a targeted treatment for adults with advanced ROS1-positive non-small cell lung cancer.
기사 원문에서 발췌했어요.
댓글 —
댓글을 불러오고 있어요…